2020 ASCO Virtual Direct™ Highlights

 

2020 ASCO Virtual Direct™ Highlights
E

2020 ASCO Update on MBC: Is Olaparib Beneficial for Disease With sBRCA1/2 or gPALB2 Mutations?

By 2020 ASCO Virtual Direct™ Highlights FEATURING Elyse Lower
By 2020 ASCO Virtual Direct™ Highlights FEATURING Elyse Lower
212 views
October 13, 2020
0 Comments
Login to view comments. Click here to Login

Featured Video

23:46
AstraZeneca Oncology

First-line Maintenance Treatment Option in Patients With HRD-Positiv…

Feat. S. Lewin

Featured Video

20:25
Exelixis

Primary Analysis and Follow-up Data of a Combination Therapy in 1L a…

Feat. S. Ratnam
Breast
06:56
2020 ASCO Virtual Direct™ Highlights

2020 ASCO Update on mTNBC: Does Atezolizumab + Chemo Combo Improve P…

Feat. E. Lower
08:33
2020 ASCO Virtual Direct™ Highlights

2020 ASCO Update on MBC: Is Olaparib Beneficial for Disease With sBR…

Feat. E. Lower
06:52
2020 ASCO Virtual Direct™ Highlights

2020 ASCO Update on HER2+ MBC: Is Tucatinib + Trastuzumab/Capecitabi…

Feat. E. Lower
06:08
2020 ASCO Virtual Direct™ Highlights

2020 ASCO Update on PIK3CA Mutated HR+ Advanced BC: Is the Addition …

Feat. E. Lower
06:32
2020 ASCO Virtual Direct™ Highlights

2020 ASCO Update on HR+ MBC: Is Fulvestrant + CDKi Associated With I…

Feat. E. Lower
08:54
2020 ASCO Virtual Direct™ Highlights

2020 ASCO HIghlights on Prostate Cancer: Does PSMA-Targeted Imaging …

Feat. V. Narayan
08:20
2020 ASCO Virtual Direct™ Highlights

2020 ASCO Update on High-Risk HER2+ Early BC: Adjuvant T-DM1 + Pertu…

Feat. K. Kalinsky
07:57
2020 ASCO Virtual Direct™ Highlights

2020 ASCO Update on HER2+ BC: Should We Add Anthracyclines to Neoadj…

Feat. K. Kalinsky
12:32
2020 ASCO Virtual Direct™ Highlights

2020 ASCO Update on HR+ BC: Does Neoadjuvant Endocrine Combination T…

Feat. K. Kalinsky
14:21
2020 ASCO Virtual Direct™ Highlights

2020 ASCO Updates on Curative HER2+ BC: Preoperative Systemic Therap…

Feat. K. Kalinsky
12:25
2020 ASCO Virtual Direct™ Highlights

2020 ASCO Update on Recent FDA Approvals for Adjuvant HER2+ EBC: Ner…

Feat. K. Kalinsky
12:38
2020 ASCO Virtual Direct™ Highlights

2020 ASCO Highlights on HER2+ MBC: Incorporating New HER2 Targeted A…

Feat. K. Kalinsky